Awareness of post-exposure prophylaxis guidelines against occupational exposure to HIV in a Mumbai hospital

Natl Med J India. 2002 Mar-Apr;15(2):69-72.

Abstract

Background: Exposure to the human immunodeficiency virus (HIV) is a matter of concern for healthcare workers. We conducted a survey to determine the level of awareness amongst operating room personnel regarding post-exposure prophylaxis in case of needlestick injuries from confirmed or suspected cases of HIV.

Methods: A structured questionnaire was presented to 39 anaesthetists and 31 surgical residents. Questions were related to identification of high risk fluids, risk of transmission, drugs, costs and procedure to be adopted for post-exposure prophylaxis.

Results: Fourteen respondents (20%) were aware of the true risk of transmission. About one-third identified all high risk fluids correctly. Fifty-five respondents (78%) correctly stated that washing the site with soap and water was the initial measure, but less than a third knew whom to contact immediately after a needlestick injury. Though 45 respondents (64%) correctly stated that prophylaxis should be initiated within 1 hour of injury, none knew exactly which drugs were to be used. Thirty respondents (42%) were aware of the use of zidovudine but none were aware of the second or third drugs used for post-exposure prophylaxis. Only 4 respondents (6%) knew the correct duration of post-exposure prophylaxis. Five respondents (7%) knew that the drugs were available in medical stores and 7 knew the approximate cost of therapy.

Conclusion: There is surprisingly poor knowledge of post-exposure prophylaxis against HIV. Ongoing awareness and training programmes are necessary to improve the same.

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Awareness
  • Blood-Borne Pathogens
  • Guidelines as Topic
  • HIV Infections / prevention & control*
  • Humans
  • India
  • Infectious Disease Transmission, Patient-to-Professional / prevention & control*
  • Needlestick Injuries*
  • Occupational Exposure
  • Risk Factors
  • Surveys and Questionnaires

Substances

  • Anti-HIV Agents